Approval · Notice of Compliance 776 · 2002
RAMACE: Notice of Compliance 776
Issued December 10, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 776
- Date
- December 10, 2002
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Angiotensin converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAMACE | 02051788 | — |
| RAMACE | 02051796 | — |
| RAMACE | 02051818 | — |
| RAMACE | 02242874 | — |